As obesity-related metabolic abnormalities include not only glucose metabolic disorders but also dyslipidemia and hypertension, our results further support the positive association between NPY and metabolic disturbances reported in the existing research literature [24]. This evidence concerns the gene NPY and obesity due to melanocortin 4 receptor deficiency.